NEWS

Krouzon Pharmaceuticals has been Selected as one of 12 High-Potential Life Science Startups for Connecticut’s Accelerator Program in 2019.

BRANFORD, CONN. (PRWEB) DECEMBER 24, 2018

ABCT, the Accelerator for Biosciences in Connecticut, announced today the second cohort of emerging biosciences ventures invited to participate in the annual program. Twelve ventures will participate in the 6.5-month-long program that features business education to develop fundable business plans and a professional network. All startups receive an entrepreneur coach, access to active business professionals and preparation to pitch to investors.

The selected startups were chosen following an extensive screening process. Expert scientists, active investors and business strategists rated the ventures based on metrics such as the strength of the team, uniqueness of insights into the problems they are solving and their capacity to revolutionize the life sciences industry.